"Designing Growth Strategies is in our DNA"

U.S. Interventional Oncology Market Size, Share & COVID-19 Impact Analysis, By Type (Radiation Therapy, Ablation Devices {Microwave Ablation, Radiofrequency Ablation, Cryoablation, and Others}, and Particle Embolization Devices {Microcatheters and Guidewires}), By Cancer Type (Lung Cancer, Liver Cancer, Kidney Cancer, and Others), By End-user (Hospitals, Specialty Clinics, and Others), and Country Forecast, 2023-2030

Last Updated: November 24, 2025 | Format: PDF | Report ID: FBI109199

 

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Cancer Diseases, in the U.S., 2022
    2. Key Industry Developments (Mergers, Acquisitions, Partnerships)
    3. Overview: Technological Advancements in Interventional Oncology
    4. Impact of COVID-19 on the Market
  5. U.S. Interventional Oncology Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Type
      1. Radiation Therapy Devices
      2. Ablation Devices
        1. Microwave Ablation
        2. Radiofrequency Ablation
        3. Cryoablation
        4. Other
      3. Particle Embolization Devices
        1. Microcatheters
        2.  Guidewires
      4. Market Analysis, Insights and Forecast – By Cancer Type
        1. Lung Cancer
        2. Liver Cancer
        3. Kidney Cancer
        4. Others
      5. Market Analysis, Insights and Forecast – By End-user
        1. Hospitals
        2. Specialty Clinics
        3. Others
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2022)
    2. Company Profiles
      1. Boston Scientific Corporation
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      2. Merit Medical Systems
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      3. Terumo Corporation
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      4. Siemens Healthcare GmbH
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      5. BD
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      6. AngioDynamics
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      7. Hologic, Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      8. Teleflex Incorporated
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Cancer Diseases, in the U.S., 2022
    2. Key Industry Developments (Mergers, Acquisitions, Partnerships)
    3. Overview: Technological Advancements in Interventional Oncology
    4. Impact of COVID-19 on the Market
  5. U.S. Interventional Oncology Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Type
      1. Radiation Therapy Devices
      2. Ablation Devices
        1. Microwave Ablation
        2. Radiofrequency Ablation
        3. Cryoablation
        4. Other
      3. Particle Embolization Devices
        1. Microcatheters
        2.  Guidewires
      4. Market Analysis, Insights and Forecast – By Cancer Type
        1. Lung Cancer
        2. Liver Cancer
        3. Kidney Cancer
        4. Others
      5. Market Analysis, Insights and Forecast – By End-user
        1. Hospitals
        2. Specialty Clinics
        3. Others
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2022)
    2. Company Profiles
      1. Boston Scientific Corporation
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      2. Merit Medical Systems
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      3. Terumo Corporation
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      4. Siemens Healthcare GmbH
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      5. BD
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      6. AngioDynamics
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      7. Hologic, Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      8. Teleflex Incorporated
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
Read Less

Figure 1: U.S. Interventional Oncology Market Revenue Breakdown (USD million, %) by Region, 2022 & 2030

Figure 2: U.S. Interventional Oncology Market Value Share (%), by Type, 2022 & 2030

Figure 3: U.S. Interventional Oncology Market Value Share (%), By Cancer Type, 2022 & 2030

Figure 4: U.S. Interventional Oncology Market Value Share (%), by End-user, 2022 & 2030

Figure 5: U.S. Interventional Oncology Market Share (%), By Company, 2022

Table 1: U.S. Interventional Oncology Market Revenue (USD million) Forecast, by Type, 2019–2030

Table 2: U.S. Interventional Oncology Market Revenue (USD million) Forecast, Ablation Devices, 2019–2030

Table 3: U.S. Interventional Oncology Market Revenue (USD million) Forecast, Embolization Devices, 2019–2030

Table 4: U.S. Interventional Oncology Market Revenue (USD million) Forecast, By Cancer Type, 2019–2030

Table 5: U.S. Interventional Oncology Market Revenue (USD million) Forecast, by End-user, 2019–2030

U.S. Interventional Oncology Market
  • 2019-2030
  • 2022
  • 2019-2021
  • 70
Download Free Sample

    man icon
    Mail icon
    Captcha refresh
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann

Related Reports